Answers are grounded in this paper and cite their sources.
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.
No takes yet. Share an insight, caveat, or question.
Cannon et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: